In a sarcoma mouse model, a combination of doxorubicin (5 mg/kg) and F8-TNFα (2 mg) was able to completely eradicate an established 70 mm3 tumor, a result unachievable by a single-agent treatment [104]. Here, TNF is linked to sarcoma.